EH
TMO icon

Equitable Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Equitable Holdings’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.17M Sell
14,295
-18
-0.1% -$8.64K 0.04% 354
2026
Q1 		$7.65M Buy
14,313
+11,105
+346% +$6.03M 0.05% 327
2025
Q4 		$1.86M Sell
3,208
-51
-2% -$28.8K 0.01% 662
2025
Q3 		$1.58M Sell
3,259
-1,041
-24% -$485K 0.01% 692
2025
Q2 		$1.74M Sell
4,300
-526
-11% -$220K 0.01% 614
2025
Q1 		$2.4M Buy
4,826
+555
+13% +$301K 0.02% 460
2024
Q4 		$2.22M Buy
4,271
+601
+16% +$330K 0.02% 463
2024
Q3 		$2.27M Buy
3,670
+890
+32% +$527K 0.02% 457
2024
Q2 		$1.54M Buy
2,780
+428
+18% +$245K 0.02% 537
2024
Q1 		$1.37M Sell
2,352
-37
-2% -$20.8K 0.02% 545
2023
Q4 		$1.27M Buy
2,389
+239
+11% +$116K 0.02% 525
2023
Q3 		$1.09M Buy
2,150
+131
+6% +$69.8K 0.02% 519
2023
Q2 		$1.05M Buy
2,019
+115
+6% +$62.1K 0.02% 505
2023
Q1 		$1.1M Sell
1,904
-35
-2% -$19.7K 0.02% 448
2022
Q4 		$1.07M Buy
1,939
+153
+9% +$81.1K 0.02% 429
2022
Q3 		$906K Buy
1,786
+154
+9% +$86.2K 0.02% 415
2022
Q2 		$887K Buy
1,632
+121
+8% +$66.6K 0.02% 433
2022
Q1 		$892K Buy
1,511
+82
+6% +$47.1K 0.01% 435
2021
Q4 		$953K Buy
1,429
+4
+0.3% +$2.5K 0.02% 410
2021
Q3 		$814K Sell
1,425
-105
-7% -$57.6K 0.01% 428
2021
Q2 		$772K Buy
1,530
+30
+2% +$14.2K 0.01% 432
2021
Q1 		$685K Sell
1,500
-17
-1% -$8.11K 0.01% 437
2020
Q4 		$707K Buy
1,517
+33
+2% +$15.5K 0.02% 384
2020
Q3 		$655K Buy
1,484
+200
+16% +$82.6K 0.02% 371
2020
Q2 		$465K Buy
1,284
+135
+12% +$45.3K 0.01% 425
2020
Q1 		$326K Sell
1,149
-152
-12% -$47.9K 0.01% 445
2019
Q4 		$423K Buy
+1,301
New +$394K 0.01% 433

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Equitable Holdings's TMO Position: Q2 2026 in Review

Equitable Holdings reduced its Thermo Fisher Scientific (TMO) stake by 0.13% in Q2 2026, selling an estimated $8.64K and leaving 14,295 shares worth $7.17M. The position accounts for 0.04% of the portfolio, ranked #354.

Equitable Holdings first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.65M in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Equitable Holdings held 14,295 shares of Thermo Fisher Scientific worth $7.17M as of Q2 2026.
  • Equitable Holdings sold 18 Thermo Fisher Scientific shares in Q2 2026, an estimated $8.64K.
  • Thermo Fisher Scientific made up 0.04% of Equitable Holdings's portfolio in Q2 2026, its #354 holding.
  • Equitable Holdings first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Equitable Holdings's Thermo Fisher Scientific position peaked at $7.65M in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.